Cambridge, United Kingdom

Olga Ignatovich

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 8.4

ph-index = 6

Forward Citations = 82(Granted Patents)


Location History:

  • Lexington, MA (US) (2023)
  • Cambridge, GB (2010 - 2024)

Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):

Title: The Innovations of Olga Ignatovich: A Leader in Antibody Engineering

Introduction: Olga Ignatovich is an esteemed inventor based in Cambridge, GB, known for her groundbreaking contributions to the field of antibody engineering. With a remarkable portfolio of 18 patents, she has established herself as a leading figure in the development of novel therapeutic strategies targeting immunological pathways.

Latest Patents: Among her most recent patents are the "Compositions monovalent for CD28 binding and methods of use," which disclose domain antibodies that specifically bind to CD28. These monovalent antibodies are designed to inhibit CD28 activity effectively. The patent details several aspects, including the use of a human domain antibody that antagonizes CD28 without significantly agonizing its activity. Additionally, Olga has developed multispecific molecules in her patent titled "Anti-TIGIT and anti-CD96 antibodies," which bind specifically to CD96 and TIGIT. This innovation includes methods for treating subjects with conditions linked to these interactions.

Career Highlights: Olga has worked with notable companies, including Domantis Limited and Bristol-Myers Squibb Company, where she has translated her innovative ideas into practical applications within the pharmaceutical industry. Her work has significantly advanced the understanding and treatment of various immunological disorders.

Collaborations: Throughout her career, Olga has had the privilege of collaborating with esteemed colleagues, including Steven G. Nadler and Suzanne J. Suchard. These partnerships have fostered an environment of creativity and innovation, leading to the development of impactful scientific advancements.

Conclusion: Olga Ignatovich's contributions to antibody engineering and her extensive patent portfolio demonstrate her commitment to scientific innovation. Her work continues to inspire future generations of inventors and researchers in the field of immunotherapy. With her pioneering spirit, Olga is poised to make even more significant strides in the world of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…